Financials
- Market Capitalization 427.7 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.09
市销率
16.57
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2952 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.49 USD | -6.04% | -0.80% | -11.39% | -2.35% | 431.12 M USD | ||
| 2959 | PRTA Prothena Corporation plc - Ordinary Shares | 8.36 USD | -0.83% | +5.42% | -6.59% | -18.99% | 429.18 M USD | ||
| 2976 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 7.82 USD | -4.63% | -2.37% | +20.49% | +11.08% | 421.70 M USD | ||
| 2979 | SLN Silence Therapeutics Plc - American Depository Share | 8.87 USD | -8.08% | -9.21% | -31.03% | +57.83% | 419.08 M USD |